Targeting Hsp90 using EC154, a novel synthetic Hsp90 inhibitor, impairs multiple oncogenic signaling pathways in human gastric and pancreatic cancer cells and reduces tumor growth in vivo

Stoeltzing, O. and Moser, C. and Lang, S. and Burrows, F. and Zhang, H. and Geissler, E. and Schlitt, H. J. (2008) Targeting Hsp90 using EC154, a novel synthetic Hsp90 inhibitor, impairs multiple oncogenic signaling pathways in human gastric and pancreatic cancer cells and reduces tumor growth in vivo. ONKOLOGIE, 31 (Suppl1). p. 134. ISSN 0378-584X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Depositing User: Petra Gürster
Date Deposited: 12 Jan 2021 16:22
Last Modified: 12 Jan 2021 16:22
URI: https://pred.uni-regensburg.de/id/eprint/31464

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.